Leigh MacConell

Company: High Tide Therapeutics

Job title: Chief Development Officer

Seminars:

Adding a Gut-Liver Targeted Metabolic Modulator Using Novel Inflammatory Pathways for Increased Metabolic Benefits 2:00 pm

Targeting novel inflammatory pathways within the gut-liver axis presents a promising strategy for developing innovative metabolic modulators Leveraging these modulators in combination with existing therapies, such as GLP-1 receptor agonists, to offer enhanced metabolic benefits, including improved weight loss, glycemic control, and reduced hepatic steatosis Providing a treatment with better ease of patient use for…Read more

day: Day One

Panel Discussion: Genetic & Phenotypic Based Approaches to Further Precision Medicine to More Effectively Combat Obesity 4:40 pm

Identifying the key biomarkers and patient characteristics that predict treatment response and adverse events to different obesity medications and interventions. Exploring the ethical and social implications of personalized obesity treatment, including access, equity, and the potential for disparities in care. Developing strategies for integrating personalized medicine approaches into routine clinical practice, including the development of…Read more

day: Day One